ClinicalTrials.Veeva

Menu

Impact of Tear Substitute Use on Dry Eye in Gamers. (HYAGAME)

Thea Pharma logo

Thea Pharma

Status

Completed

Conditions

Evaporative Dry Eye

Treatments

Other: Preservative free hyaluronic acid artificial tear

Study type

Interventional

Funder types

Industry
Other

Identifiers

NCT05536661
THEA-HYA-GAMERS-2019-01

Details and patient eligibility

About

Clinical, prospective, comparative, controlled, single-blind study, on the signs and symptoms of dry eye before and after 3 days of playing video games with the use of artificial tears (Hyabak) versus no intervention.

Full description

Adult attendees to a Gamers convention will complete questionnairs and undergo an opthalmological evaluation before and after playing for 3 days in a row. Participants will be randomized into 2 groups of equal size:

  1. Study group.
  2. Control group. The Study group will instill hyaluronic acid 0.15% artificial tears in both eyes 4 times a day during the 3 days of the video game session, while the control group will not instill artificial tears.

Enrollment

56 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • 18 years or older
  • Participants in videogame convention planning to play video games for a minimum of 6 hours daily for the next 3 days.
  • Voluntarily accept to participate and sign informed consent form

Exclusion criteria

  • Ocular, nasolagrimal or palpebral active condition different from dry eye disease.
  • History of ocular trauma or infecction in the last 3 months previous to inclusion.
  • History of refractive surgery.
  • Visual acuity 0.5 or less in at least 1 eye.
  • Ocular medication use in the 3 days prior to inclusion.
  • History of systemic condition asociated to dry eye.
  • Use of systemic medication known to induce dry eye in the last 30 days.
  • Known allergy to hyaluronic acid.
  • Pregnant or lactating women.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

56 participants in 2 patient groups

Study group
Experimental group
Description:
Preservative free Hyaluronic acid 0.15% artificial tear instilled in both eyes 4 times daily for 3 days
Treatment:
Other: Preservative free hyaluronic acid artificial tear
Control group
No Intervention group
Description:
No artificial tear instilation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems